13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups

This publication has 36 references indexed in Scilit:

• Epidemiology of Invasive Pneumococcal Disease Among High-Risk Adults Since the Introduction of Pneumococcal Conjugate Vaccine for Children
  Clinical Infectious Diseases, 2012
• Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis
  BMJ, 2012
• Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
  The Lancet Infectious Diseases, 2011
• Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific Streptococcus pneumoniae antigen in urine samples
  Journal of Medical Microbiology, 2011
• A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
  New England Journal of Medicine, 2010
• Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary Disease
  American Journal of Respiratory and Critical Care Medicine, 2009
• Invasive Pneumococcal Disease among Adults: Associations among Serotypes, Disease Characteristics, and Outcome
  Clinical Infectious Diseases, 2009
• Efficacy of pneumococcal vaccination in adults: a meta-analysis
  Canadian Medical Association Journal, 2009
• Invasive pneumococcal infections among persons with and without underlying medical conditions: Implications for prevention strategies
  BMC Infectious Diseases, 2008
• Clonal and Capsular Types Decide Whether Pneumococci Will Act as a Primary or Opportunistic Pathogen
  Clinical Infectious Diseases, 2006